Upfront Allogeneic HCT vs Remission Induction Chemotherapy Followed by Allogeneic HCT for Acute Myeloid Leukemia With Multilineage Dysplasia: A Propensity Score Matched Analysis

American Journal of Hematology - United States
doi 10.1002/ajh.25336
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Acute Myeloid Leukemia With Mutated NPM1 Demonstrating Multilineage Dysplasia and Marked Thrombocytosis

British Journal of Haematology
Hematology
2017English

Recipient Pre-HCT Telomere Length and Outcomes After Unrelated Donor HCT for Acute Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Disease Progression Is Main Barrier to Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Prognostic Impact of Variant Allelic Frequency of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Inferior Outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in First Complete Remission as Compared to De Novo Acute Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2020English

Response: Chemotherapy Versus Allogeneic Transplantation in Adult Patients With Acute Lymphoblastic Leukemia in First Remission--Not a Time for Dogma

Blood
BiochemistryImmunologyCell BiologyHematology
2013English

Allogeneic Hematopoietic Cell Transplantation in First Remission Abrogates Poor Outcomes Associated With High-Risk Pediatric Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Lower Uric Acid Level at the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy